Sarepta Therapeutics, Inc. - Common Stock (SRPT)

CUSIP: 803607100

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / Common Stock
Shares outstanding
104,849,534
Total 13F shares
26,596,410
Share change
-770,731
Total reported value
$639,243,096
Put/Call ratio
89%
Price per share
$24.03
Number of holders
114
Value change
-$12,446,044
Number of buys
67
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 803607100?
CUSIP 803607100 identifies SRPT - Sarepta Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
3.3%
3,484,579
$70,981,000 31 Dec 2013
13F
COLUMBIA WANGER ASSET MANAGEMENT LLC
13F
Company
2.5%
2,635,000
$53,675,000 31 Dec 2013
13F
VANGUARD GROUP INC
13F
Company
2%
2,061,338
$41,990,000 31 Dec 2013
13F
LORD, ABBETT & CO. LLC
13F
Company
1.7%
1,764,508
$35,943,000 31 Dec 2013
13F
BlackRock Fund Advisors
13F
Company
1.3%
1,363,153
$27,767,000 31 Dec 2013
13F
STATE STREET CORP
13F
Company
1.3%
1,346,830
$27,429,000 31 Dec 2013
13F
FMR LLC
13F
Company
1%
1,079,933
$21,998,000 31 Dec 2013
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.95%
994,843
$20,265,000 31 Dec 2013
13F
Visium Asset Management, LP
13F
Company
0.81%
850,400
$17,323,000 31 Dec 2013
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.81%
844,611
$17,205,000 31 Dec 2013
13F
Broadfin Capital, LLC
13F
Company
0.69%
726,655
$14,801,000 31 Dec 2013
13F
SAC Capital Advisors LP
13F
Company
0.68%
711,777
$14,499,000 31 Dec 2013
13F
Jefferies Group LLC
13F
Company
0.64%
669,462
$13,637,000 31 Dec 2013
13F
D. E. Shaw & Co., Inc.
13F
Company
0.6%
631,413
$12,862,000 31 Dec 2013
13F
KORNITZER CAPITAL MANAGEMENT INC /KS
13F
Company
0.58%
612,075
$12,468,000 31 Dec 2013
13F
Granahan Investment Management, LLC
13F
Company
0.51%
538,504
$10,969,000 31 Dec 2013
13F
NORTHERN TRUST CORP
13F
Company
0.51%
535,775
$10,914,000 31 Dec 2013
13F
SABBY MANAGEMENT, LLC
13F
Company
0.48%
507,700
$10,342,000 31 Dec 2013
13F
EMERALD ADVISERS, LLC
13F
Company
0.43%
448,937
$9,145,000 31 Dec 2013
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.4%
416,346
$8,481,000 31 Dec 2013
13F
CAPITAL FUND MANAGEMENT S.A.
13F
Company
0.35%
369,536
$7,527,000 31 Dec 2013
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.28%
298,651
$6,083,000 31 Dec 2013
13F
COMMERZBANK AKTIENGESELLSCHAFT /FI
13F
Company
0.22%
235,771
$5,748,000 31 Dec 2013
13F
BARCLAYS PLC
13F
Company
0.26%
276,803
$5,536,000 31 Dec 2013
13F
SOROS FUND MANAGEMENT LLC
13F
Company
0.22%
233,000
$4,746,000 31 Dec 2013
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.2%
208,742
$4,252,000 31 Dec 2013
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.19%
197,574
$4,025,000 31 Dec 2013
13F
GROUP ONE TRADING LLC
13F
Company
0.18%
193,678
$3,945,000 31 Dec 2013
13F
Bank of New York Mellon Corp
13F
Company
0.17%
178,293
$3,632,000 31 Dec 2013
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
171,813
$3,499,000 31 Dec 2013
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.14%
147,444
$3,003,000 31 Dec 2013
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.14%
141,800
$2,888,000 31 Dec 2013
13F
CREDIT SUISSE AG/
13F
Company
0.13%
136,276
$2,776,000 31 Dec 2013
13F
A.R.T. Advisors, LLC
13F
Company
0.12%
130,965
$2,667,000 31 Dec 2013
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.11%
117,253
$2,388,000 31 Dec 2013
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.1%
110,078
$2,242,000 31 Dec 2013
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.1%
108,600
$2,172,000 31 Dec 2013
13F
BlackRock Investment Management, LLC
13F
Company
0.1%
102,968
$2,097,000 31 Dec 2013
13F
DEUTSCHE BANK AG\
13F
Company
0.09%
94,618
$1,926,000 31 Dec 2013
13F
UBS AG
13F
Company
0.09%
93,262
$1,900,000 31 Dec 2013
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.09%
89,728
$1,828,000 31 Dec 2013
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.08%
80,000
$1,630,000 31 Dec 2013
13F
Paloma Partners Management Co
13F
Company
0.07%
75,572
$1,540,000 31 Dec 2013
13F
Iguana Healthcare Management, LLC
13F
Company
0.07%
70,000
$1,426,000 31 Dec 2013
13F
HIGHLAND CAPITAL MANAGEMENT LP
13F
Company
0.07%
69,314
$1,412,000 31 Dec 2013
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
68,082
$1,387,000 31 Dec 2013
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.06%
67,300
$1,371,000 31 Dec 2013
13F
MORGAN STANLEY
13F
Company
0.05%
57,064
$1,163,000 31 Dec 2013
13F
TEACHERS ADVISORS, LLC
13F
Company
0.05%
54,559
$1,111,000 31 Dec 2013
13F
Benchmark Capital Advisors
13F
Company
0.04%
42,900
$874,000 31 Dec 2013
13F

Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q1 2014

As of 31 Mar 2014, Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,596,410 shares. The largest 10 holders included LORD, ABBETT & CO. LLC, PERCEPTIVE ADVISORS LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, FMR LLC, BlackRock Institutional Trust Company, N.A., GILDER GAGNON HOWE & CO LLC, and D. E. Shaw & Co., Inc.. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2014 vs Q4 2013 Across Filers

Q4 2013 holders
109
Q1 2014 holders
114
Holder diff
5
Investor Q4 2013 Shares Q1 2014 Shares Share Diff Share Chg % Q4 2013 Value $ Q1 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .